Breast Neoplasms D001943

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Breast Neoplasms

Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Breast Diseases » Breast Neoplasms

Description

Tumors or cancer of the human BREAST.   MeSH

Subtype Terms (8)

Breast Carcinoma In Situ
12 drugs (11 approved, 1 experimental)

Breast Neoplasms, Male
100 drugs (59 approved, 41 experimental)

Carcinoma, Ductal, Breast
12 drugs (8 approved, 4 experimental)

Carcinoma, Lobular
3 approved drugs

Hereditary Breast and Ovarian Cancer Syndrome
5 drugs (3 approved, 2 experimental)

Inflammatory Breast Neoplasms
44 drugs (36 approved, 8 experimental)

Triple Negative Breast Neoplasms
297 drugs (85 approved, 212 experimental)

Unilateral Breast Neoplasms
 


Phase 4 Indicated Drugs (80)

Phase 3 Indicated Drugs (216)

Phase 2 Indicated Drugs (603)

13-deoxydoxorubicin

177lu-dotatoc

18f-ffnp

18f-fluciclatide

2-fluoropropionyl-labeled pegylated dimeric rgd peptide

2x-121

68ganota-anti-her2 vhh1

89zr-trastuzumab

99mtc-rhannexin v-128

99mtc-sc

a166

abt-751

abt-869

acolbifene

activated cik and cd3-muc1 bispecific antibody

adavosertib

adenoviral vector expressing hsv-tk

ad-rts-hil-12

ae37 + gm-csf vaccine

afimoxifene

aflibercept (zaltrap)

afp464

agatolimod

aip-303

aldoxorubicin

alecsat

alectinib (alecensa)

alemtuzumab (campath)

alisertib

allogeneic gm-csf-secreting breast cancer vaccine

allogeneic hematopoietic stem cells (Hemacord)

allogeneic lymphocytes

allogeneic tumor cell vaccine

allo lmi vaccine

allostim

alovudine

alt-803

alvac-cea vaccine

alvespimycin

alx148

amifostine (ethyol)

amino acids (Freamine)

aminoflavone prodrug

amonafide dihydrochloride

amrubicin

anastrazole

anlotinib

anti-egfr immunoliposomes loaded with doxorubicin

anti-her2/her3 dendritic cell vaccine

antineoplaston a10

anti-ny eso-1 mtcr pbl

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin)

anx-510

apitolisib

apricoxib

armodafinil (nuvigil)

arsenic trioxide (trisenox)

arx788

as15

ashwagandha extract

atropine

autologous-allogeneic tandem hematopoietic stem cell

autologous dendritic cells

autologous dendritic cells loaded with autologous tumor lysate

autologous hematopoietic cell

autologous lymphocytes

autologous natural killer cells

auy922

avapritinib (Ayvakit)

ave-1642

avelumab (bavencio)

azacitidine (vidaza)

azd-4547

azd-5672

azd6738

bay86-7548

bay94-9392

bazedoxifene (Duavee)

becatecarin

bendamustine (treanda)

beractant (survanta)

bexarotene (targretin)

bgb-290

bi-2536

bi 831266

biib021

binimetinib (mektovi)

bintrafusp alfa

bismuth subsalicylate

bivalent oral polio vaccine (bopv), type 1 and type 3

bleomycin (blenoxane)

bms-690514

bms754807

bortezomib (velcade)

bosutinib (bosulif)

bp102

bp-c1

briavax

brigatinib (alunbrig)

bryostatin

butylphthalide

bzl101

cabazitaxel (jevtana kit)

cabozantinib (cometriq)

Caesalpinia spinosa

caffeine

calcitriol (rocaltrol)

calcium glucarate

cam-h2

canagliflozin (invokana)

canertinib

carbomer

carotuximab

cb-103

cb-839

cblb612

cc-223

cc-486

cdx-301

cediranib

cemiplimab (libtayo)

cephalexin (keflex)

ceralasertib

ceramide

cetuximab (erbitux)

cfi-400945

chloroquine

chondroitin

ci-1040

cixutumumab

clonidine (catapres)

clopidogrel (plavix)

cobimetinib (cotellic)

colestipol (colestid)

conjugated estrogen

copanlisib (aliqopa)

copper (cu-7)

cp-724714

cr1447

crizotinib (xalkori)

crofelemer (mytesi)

ct7001

curcumin

custirsen

cx-072

cx-2009

cyanocobalamin (berocca)

dabrafenib (tafinlar)

dacomitinib (vizimpro)

dactolisib

dapagliflozin (farxiga)

darolutamide (Nubeqa)

dasatinib (sprycel)

dc1 vaccine

dc-cik cells

dcfpyl

dec-205/ny-eso-1 fusion protein cdx-1401

decitabine (dacogen)

defactinib

deferasirox (exjade)

degarelix acetate (firmagon)

dendritic cells

denileukin diftitox (ontak)

deslorelin

desmopressin (ddavp)

dher2

digoxin (lanoxin)

dimethyl sulfoxide (rimso)

dinaciclib

disulfiram (antabuse)

docosahexaenoic acid

donepezil (aricept)

dostarlimab

dovitinib

doxepin (sinequan)

doxycycline (vibramycin)

durvalumab (imfinzi)

dusigitumab

e 7070

edotecarinum

efalex

elu001

emtansine

endoxifen

eniluracil

enmd 2076

entrectinib (Rozlytrek)

envafolimab

enzastaurin

epacadostat

epinephrine (levophed)

epothilone

era923

erlotinib (tarceva)

ertumaxomab

erythromycin (ilosone)

esomeprazole (nexium)

estetrol

estramustine (emcyt)

estrogens, esterified (menrium component estrogens, esterified)

etarfolatide

etbx-011

etbx-051

etbx-061

ethanol

exatecan mesylate

ex vivo-expanded her2-specific t cells

ezn-2208

f16il2

famitinib

faza

fcn-437c

fdht

fec

ferric hydroxide saccharate

fesoterodine (toviaz)

ficus septica leaf extract

figitumumab

fludarabine (fludara)

fludeoxyglucose f-18

fluocinonide (lidex)

fluorofuranylnorprogesterone

fluoromisonidazole

fluvastatin (lescol)

foretinib

fralpha vaccine

futibatinib

ganetespib

ganitumab

gc1008

gdc-0084

gdc-0810

gedatolisib

gelatin

gen1044

genistein

germanium

gi-4000

gi-6207

gi-6301

ginseng

glembatumumab vedotin

glucosamine

glutathione

glycerin

gm-csf vaccine

gp2 peptide

grapiprant

green tea

grn163l

gs-5829

gsk2302024a

gsk-2636771

gsk3326595

gti-2040

guarana extract

h3b-6545

her2 bats

her2bi-armed activated t cells

her2 dc1 vaccine

her-2 icd peptide

her-2/neu peptide vaccine

hs-10342

hu3s193

hyaluronic acid

hyaluronidase (human recombinant) (hylenex)

hydralazine (apresoline)

hydrogen peroxide

hydromorphone (diladid)

hydroxocobalamin (cyanokit)

hydroxychloroquine (plaquenil)

icotinib

icrucumab

idarubicin (idamycin)

idasanutlin

ifosfamide (ifex)

il-7

imiquimod (aldara)

imp288

imprime pgg

inactivated influenza vaccine

incmga00012

indibulin

indomethacin (indocin)

indoximod

infigratinib

infliximab (remicade)

ingn 201

int230-6

interferon alpha-2b (Intron-A)

interleukin-12

ipi-549

ipilimumab (yervoy)

irosustat

irx-2

isis 5132

isoflavone

ispinesib

itacitinib

ketoconazole (nizoral)

kn026

lag-3

laniquidar

larotrectinib (vitrakvi)

lasofoxifene

lcl-161

leflunomide (arava)

lenvatinib (lenvima)

l-epigallocatechin

linsitinib

lisinopril (zestril)

litronesib

ln-145

lobaplatin

lonaprisan

loratadine (claritin)

losartan (cozaar)

lovastatin (mevacor)

lucitanib

lurbinectedin

lutetium dotatate lu-177 (Lutathera)

ly900003

mage-a1-specific t cell receptor-transduced autologous t-cells

magnesium oxide

mango juice

mcla-128

mcs110

medi4276

medi-6469

mercaptopurine (purinethol)

mesalamine (rowasa)

methylene blue (proveblue)

mgi-114

milk protein

mineral oil

mirvetuximab soravtansine

mk-0646

mk-0752

mk-1775

modified vaccinia ankara-5t4 vaccine

monalizumab

monosialic gangliosides

montanide isa51

motesanib

mrg002

msk-2206

muc1 car-t cells

multi-epitope folate receptor alpha peptide vaccine

myelo001

n803

naproxen (naprosyn)

nbtxr3

nelipepimut-s

neoantigen reactive t cells

neostigmine (bloxiverz)

nicotinamide

nicotine (nicorette)

nimesulide

nimotuzumab

nintedanib (ofev)

nir178

nk-92

nk cell

nktr-214

nuv-422

nystatin (mycostatin)

oblimersen sodium

odm-209

oleclumab

omaveloxolone

omega-3 fatty acids (omacor)

omeprazole (prilosec)

omt-111

onapristone

onartuzumab

onc201

onc-392

onco-peptide loaded autologous dendritic cells

op-1250

oprelvekin (Neumega)

opt-822/opt-821

or2805

ortataxel

orteronel

osimertinib (tagrisso)

oxaloacetate

p10s-padre

palm oil glyceride

panitumumab (vectibix)

panobinostat (farydak)

pantoprazole (protonix)

panvac

pasireotide (signifor)

patent blue v dye

patritumab

pazopanib (votrient)

pd-0325901

pd-l1 t-hank

pd l 506

pelareorep

pemetrexed (alimta)

pemigatinib

perifosine

perillyl alcohol

peripheral blood lymphocytes

peripheral blood progenitor cells carrying mdr1

periplaneta americana

personalized synthetic long peptide vaccine

pexidartinib (Turallo)

pf-04518600

pf-04691502

pf-04878691

pf-06873600

pf-07104091

pf3084014

phenylacetic acid (ucephan)

phenylacetylgluatmine

pictilisib

pimasertib

pioglitazone (actos)

pixuvri

plicamycin (mithracin)

pngvl3-hicd vaccine

pol6326

polycarbophil

poly-iclc

polysaccharide-k

ponatinib (iclusig)

poziotinib

pqr309

pralatrexate (folotyn)

pravastatin (pravachol)

prexasertib

proanthocyanidin extract

progenta

propranolol (inderal)

provera

pumvc3-igfbp2-her2-igf1r plasmid dna vaccine

pvx-410

pyrazoloacridine

rad001

radium-223 (xofigo)

ralimetinib

rapa-201 autologous t cells

ras peptide cancer vaccine

rebimastat

receptal

recombinant adenoviral human p53 gene

recombinant fowlpox-cea(6d)/tricom vaccine

regorafenib (stivarga)

reolysin

reparixin

retifanlimab

rgd-k5

ribavirin (virazole)

ridaforolimus

rifaximin (xifaxan)

rintatolimod

ritonavir (Norvir)

rituximab (rituxan)

ro4929097

romidepsin (istodax)

rosuvastatin (crestor)

rq-00000007

rubitecan

rucaparib (rubraca)

ruxolitinib (jakafi)

s81694

sacubitril (Entresto)

sagopilone

samarium-153 lexidronam (quadramet)

sapanisertib

sapitinib

sar408701

sar439281

saracatinib

satoreotide tetraxetan

satoreotide trizoxetan

satraplatin

sbt6050

sc10914

sch66336

secoisolariciresinol

selinexor (Xpovio)

selumetinib

sepantronium bromide

seribantumab

seviteronel

sgn-15

shr-1316

shr-1701

shr2554

shr3162

shr3680

shr7390

simvastatin (zocor)

sintilimab

sirolimus (rapamune)

sitravatinib

sm-88

snk01

sodium deoxyribonucleate

sodium dichloroacetate

sodium l-triiodothyronine

sodium selenium oxide

sodium thiosulfate

solifenacin (vesicare)

sonidegib (odomzo)

sontuzumab

spartalizumab

stem cells

su14813

sulforaphane

sulindac (clinoril)

suramin

sv-br-1-gm

synthetic tumor-associated peptide vaccine therapy

talimogene laherparepvec (Imlygic)

tanespimycin

tanibirumab

tarloxotinib

tasisulam

tc-99m albumin

temozolomide (temodar)

tenalisib

teprotumumab

tesevatinib

tetanus-diphtheria toxoid

tetrahydrouridine

thalidomide (Thalomid)

tigatuzumab

tiomolibdate ion

tipiracil (lonsurf)

tislelizumab

titanium silicide

tivantinib

tlk286

tocilizumab (actemra)

tocotrienol

topotecan (hycamtin)

toripalimab

tpi-287

tpiv100

tq-b3525

tqb3616

trabectedin (yondelis)

trametinib (mekinist)

trebananib

tremelimumab

triapine

triciribine

trifluridine (viroptic)

trx518

ts-108

tt-00420

tumor associated antigen specific cytotoxic t lymphocytes

tumor-pulsed dendritic cells

tumour infiltrating lymphocytes

tvb-2640

tw1025

u3-1402

ulipristal (ella)

upamostat

uprosertib

utomilumab

v3-mommo

vaccinia-cea(6d)-tricom vaccine

vaccinia-cea vaccine

valaciclovir (Valtrex)

valproic acid (depakene)

valsartan (diovan)

valspodar

vandetanib (caprelsa)

varlitinib

vatalanib

veledimex

vemurafenib (zelboraf)

venetoclax (venclexta)

verteporfin (visudyne)

veru-111

vigil

vinblastine (velban)

vincristine (oncovin)

vismodegib (erivedge)

vistusertib

vls-101

vorinostat (zolinza)

vrp-her2

vynfinit

wokvac

xentuzumab

xianlinggubao

y90 edotreotide

young tumor infiltrating lymphocytes

zafirlukast (accolate)

zarnestra

zb716

zhongyaofufang

zibotentan

zn-c3

zoptarelin

zw25

10 valent pneumococcal conjugate vaccine

Phase 1 Indicated Drugs (429)

111in-daclizumab

131i-sgmib anti-her2 vhh1

131i-tenatumomab

131i-tm-601

18f-2-fluoro-2-deoxy-d-glucose fluorodeoxyglucose

18f-asis

18f dpa-714

18f-fluoroacetate

18f-fluorobenzyl triphenyl phosphonium

18f fluorthanatrace

18f-fmau

18f iso

18f iso-1

18f-αvβ6-bp

23-valent pneumococcal polysaccharide vaccine (pneumovax-23)

2-fluorofucose

68ga-nodaga-e(c[rgdyk])2

68ga-nota-ae105

68ga-nota-bbn-rgd

68ga-psma

7-hydroxystaurosporine

95-5-49

95-6-22

99mtc gp

9 peptides from her-2/neu, cea, & cta

ab928

abbv-075

abbv-085

abbv-181

abbv-368

abbv-927

abexinostat

abt-767

ac682

ace1702

acetylcysteine (mucomyst)

adct-502

adenoviral vector encoding rat her-2/neu

adenovirus-mediated human interleukin-12

adher-2/neu transduced dendritic cells

ad-sig-hmuc-1/ecdcd40l vaccine

afuresertib

aglatimagene besadenovec

alfatide

alfatide ii

alitretinoin (panretin)

allogeneic natural killer cells

alpha-tocopheryloxyacetic acid

alprostadil (prostin)

alrn-6924

alt-p7

amlodipine (norvasc)

anakinra (kineret)

antigen-loaded cultured dendritic cells

anti-ny eso-1 tcr-transduced t cells

aprotinin (trasylol)

arg1-18,19,20

artesunate

arv-471

asn004

astx727

atrc-101

autologous ad her2 dendritic cells

autologous cd19/cd22 chimeric antigen receptor t-cells

autologous cd34+ cells

autologous t cells

autologous tumor infiltrating lymphocytes

ava6000

avb-620

avx901

azd5153

azd5305

azd5363

azd8186

azd-8186

azd8835

azd9496

b002

B003

bacille calmette-guerin

bay2701438

bcd-115

belinostat (beleodaq)

berzosertib

bi-con-02

birabresib

bivatuzumab mertansine

bms-599626

btp-114

c-11 pib

cabergoline (dostinex)

cal

canakinumab (ilaris)

capmatinib

carboxyamidotriazole

carfilzomib (kyprolis)

cct303-406

cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine

cd133 car-t cells

cd80 breast cancer vaccine

cdca1, urlc10, kif20a, depdc1 and mphosph1

cdx-1140

cdx1307

cdx-527

cea gene modified t cells

cea-loaded dendritic cells

cefepime (maxipeme)

chp-her2, chp-ny-eso-1

cilengitide

cirmtuzumab

cjm112

clostridium novyi-nt spores

cmet cart cells

coconut oil

com701

coprelotamab

coriolus versicolor

cp-18

creatine

cs-1000 labeled svf cells

ct-0508

ctap101

cu64-dota b-fab

cu64 trastuzumab

cudc-101

cva21

cyh33

d-0502

dacarbazine (dtic-dome)

d-arabino-2-desoxyhexose

daratumumab (darzalex)

daunoxome

dc vaccine

dcvax-direct

dhes0815a

diazepinomicin

dibenzyl trisulphide

diclofenac (voltaren)

dimethane sulfonate

d-limonene

dnx-2440

dpx-0907

dpx-survivac

ds-1062a

dzd1516

e7090

ef5

eftilagimod alpha

egf816

elimusertib

epcam car-t cells

erdafitinib (Balversa)

esr1 peptide vaccine

fate-nk100

ferumoxytol (feraheme)

fingolimod (gilenya)

Fluciclovine (Axumin)

fluvoxamine (luvox)

folate-fluorescein conjugate

fowlpox-sargramostim

foxy-5

fruquintinib

fs-1502

g1t48

galunisertib

gbr 1302

gd2 car t cells

gdc-0927

gem3psca

gm2-klh vaccine

gm-ct-01

gmi-1359

gnc-035

gq1001

gs-5745

gsk719125

gz17-6.02

h2nvac

hc-5404-fu

hepatitis a vaccine, inactivated (vaqta)

hepatitis b vaccine (recombinant) (recombivax)

her2-peptid-vakzine

hf10

hrs8807

hs-10352

hsa-gcsf

htert/survivin multi-peptide vaccine

humnc2-car44 car t cells

iacs-010759

icaritin

icasp9m28z t cell infusions

idc-g305

idelalisib (zydelig)

idoxuridine (herplex)

igf-methotrexate

il-1

il-4(38-37)-pe38kdel

imexon

imm2902

imp4297

in111 monoclonal antibody bre-3

in111 monoclonal antibody m170

incb047986

incb050465

incomplete freund's adjuvant

indole-3-carbinol

ino-1400

ino-9012

interferon alfa-1b

interferon alpha-2a (roferon-a)

interleukin-10

iohexol (Omnipaque)

iopamidol (Isovue)

iph5301

irbinitinib

irgd

isa-720

iso-1

itraconazole (sporanox)

ivac_m_uid

ivac_w_bre1_uid

ixazomib (ninlaro)

jab-3312

khk2375

ks24.22 cells

kw-2450

l19tnf

lag525

lfa102

ljm716

lmb-9

l-nmma

lorcaserin (belviq)

lsz102

ltx-315

lum015

lx-039

lxi-15029

ly-3023414

ly-3039478

ly3143921

ly3300054

lyt-100

m170

mage-12 peptide vaccine

mag-tn3

mammaglobin-a dna vaccine

martinostat

me-344

men1611

merestinib

mesothelin car t cells

metarrestin

mfe23 scfv-expressing autologous anti-cea mfez t lymphocytes

mgd009

mgd013

mimotope p10s-padre

minnelide

mistletoe extract

mixed bacterial vaccine

mkc1106

mln8054

mm-111

mocetinostat

modified vaccinia virus ankara vaccine expressing p53

monoclonal antibody 3a1

morab-066

motexafin gadolinium

motolimod

mrna-2752

mrx0518

mubritinib

muc1-klh vaccine/qs21

muc1 peptide

mva-bn-her2

mva-brachyury-tricom

mvf-her-2 (266-296)

mvf-her-2(597-626)

mvf-her-2(628-647)-crl 1005 vaccine

naptumomab estafenatox

neoantigen dna vaccine

nilotinib (tasigna)

nis793

njh395

nk012

novobiocin (albamycin)

np-g2-044

nx-1607

nzv930

obi-821

obi-833

obinutuzumab (gazyva)

ocpm immunotherapeutic vaccine

Octafluoropropane

onalespib

oncolytic measles virus encoding helicobacter pylori neutrophil-activating protein

oncolytic measles virus encoding thyroidal sodium iodide symporter

oncolytic virus cf33-expressing hnis/anti-pd-l1 antibody

oncr-177

ont-10

orantinib

orax

ots167

papaverine

paricalcitol (zemplar)

parsaclisib

pegvisomant (somavert)

pegylated arginine deiminase

personalized neoantigen vaccine

pf-06263507

pf-06650808

pf-06804103

pf-06946860

pf-06952229

pf-07220060

pf-07248144

pf-07260437

phenelzine (nardil)

phentolamine mesylate (regitine)

picoplatin

pidilizumab

pmd-026

pneumococcal 13-valent conjugate vaccine (prevnar 13)

prostate specific membrane antigen

proxalutamide

prs-343

prt1419

prt2527

ptc299

ptk7-adc

pu-h71

pumvc3-igfbp2-her2-igf1r

pvsripo

py314

qbs10072s

rad140

rad-1901

rbx7455

rebastinib

retinoid 9cuab30

revlimid

ricolinostat

riluzole (rilutek)

rimiducid

riviciclib

ro5479599

ro6874281

rogaratinib

romiplostim (nplate)

ror1 car-specific autologous t-lymphocytes

roscovitine

rose bengal disodium

rp12146

rv-df3/muc1

rvv-740cta

sc-005

selatinib ditosilate

sgn-b6a

sgn-cd228a

sgn-cd47m

sgn-stnv

shr9549

sildenafil (viagra)

silicon phthalocyanine

silmitasertib

sn132d

sn-38

sparc1210

sparc1613

stem cell factor

sy-1365

sy-5609

syn-004

synthetic breast cancer peptides

taest16001

tak-500

taladegib

talaporfin sodium

tariquidar

tas-102

tas2940

technetium tc-99m sestamibi

telomerase: 540-548 peptide vaccine

tenifatecan

tetanus toxoid

tgfbeta resistant her2/ebv-ctls

th1902

th2

tils and car-tils targeting her2, mesothelin, psca, muc1, lewis-y, gpc3, axl, egfr, claudin18.2/6, ror1, gd1, or b7-h3

tkm-080301

tomivosertib

tozuleristide

tq-b2450

transferrin receptor-targeted liposomal p53 cdna

tricom-cea(6d)

trimix

trodusquemine

ttc-352

tti-101

tti-621

tumor blood vessel antigen peptide-pulsed alpha-type-1 polarized dendritic cell

ty-302

utidelone

v934-ep

v935

vaccinia-muc1 vaccine

vaccinia-tricom vaccine

vantictumab

varlilumab

veldoreotide

vitamin q

vm206

vvdd-cdsr

white button mushroom extract

xl092

xl102

xmab20717

xmab23104

xmt-1522

y90 monoclonal antibody b3

y90 monoclonal antibody bre-3

y90 monoclonal antibody m170

ye-neo-001

zen-3694

zn-a-1041

zn-c5

zw49

zymosan

α-lactalbumin vaccine

Other Experimental Indicated Drugs (111)


Organization Involved with Phase 4 Indications (118)

Organization Involved with Phase 3 Indications (476)

Aalborg University

Aarhus University

AbbVie

Academic and Community Cancer Research United

Actavis

Agenzia Italiana del Farmaco

Aichi Medical University

Airlangga University

Akron City Hospital

Alliance Foundation Trials

AMAG Pharmaceuticals, Inc.

American College of Surgeons

Amgen

Angiochem Inc

Anhui Medical University

Arbeitskreis Klinische Studien

ARCAGY-GINECO

AryoGen Pharmed Co.

Association Francaise pour la Recherche Thermale

Astellas

Athenex, Inc.

Australia and New Zealand Breast Cancer Trials Group

Austrian Breast and Colorectal Cancer Group

Aventis

Avid Bioservices

Baotou Medical University

Barts & The London NHS Trust

Barwon Health

Bayer

Ben Gurion University

Bethune International Peace Hospital

Biocad

BioNumerik Pharmaceuticals, Inc.

Biostar

Biothera

Boehringer Ingelheim

Bornholms Regionskommune

Borstkanker Onderzoek Groep

Brazilian Breast Cancer Study Group (GBECAM)

Breast Cancer Research Foundation

British Association of Surgical Oncology: Breast Group

British Columbia Cancer Agency

Brown University

Byondis

Canadian Cancer Society

Canadian Cancer Trials Group

Cancer and Leukemia Group B (CALGB)

Cancer International Research Group

Cancer Research Campaign

Cancer Research for the Ozarks

Cancer Research UK

Cancer Trials Ireland

Cantonal Hospital of St. Gallen

Capital Medical University

Cardiff University

Cascadian Therapeutics Inc.

Case Western Reserve University

Celgene

Celltrion

Center Eugene Marquis

Central European Cooperative Oncology Group

Central Hospital, Zibo

Central South University

Centre Leon Berard

Centre Medical Ville-Marie

Centro di Riferimento Oncologico - Aviano

Centro Hospitalar Lisboa Ocidental

Centro Oncologico de Excelencia

Centro Oncológico de Galicia

Champalimaud Cancer Center

Changhai Hospital

Chao Family Comprehensive Cancer Center

Chengde Medical University

China Breast Cancer Clinical Study Group

China Medical University

China National Biotec Group Co., Ltd

Chinese Anti-Cancer Association

Chinese University of Hong Kong

Chipscreen Biosciences, Ltd.

Chongqing Medical University

CHU Besançon

Chugai

Chung-Ang University

City of Hope National Medical Center

C. Klien and Associates

Clinical Research Technology S.r.l.

Complejo Hospitalario de Especialidades Juan Ramón Jimenez

Complejo Hospitalario Juan Canalejo

Comprehensive Support Project for Oncology Research

Consorci Sanitari de Terrassa

Cornell University

Daehwa Pharmaceutical Co., Ltd.

Daiichi Sankyo

Dako

Dalian Medical University

Danish Breast Cancer Cooperative Group

Danish Cancer Society

Dartmouth University

Department of Defense

Dexa Medica Group

Dharmais National Cancer Center Hospital

Dong-A Pharmaceutical

Dutch Cancer Society

Eastern Cooperative Oncology Group

EBEWE Pharma

ECOG-ACRIN Cancer Research Group

EddingPharm Oncology Co., LTD.

EirGenix, Inc.

Elkhart General Hospital

EndoCeutics Inc.

Epoch Biosciences

Erciyes University

ERYtech Pharma

Eske Corporation S.A.C

Essex Pharma

Eurofarma Laboratorios S.A.

European Organisation for Research and Treatment of Cancer

Everest Medicines

Ev. Hospital Bethesda, Moenchengladbach

Facing Our Risk of Cancer Empowered

Fairfax Northern Virginia Hematology Oncology, PC - Fairfax

Finnish Breast Cancer Group

Flower Hospital Cancer Center

Fondazione Giovanni Pascale

Fondazione Michelangelo

Fonden Til Fremme af Klinisk- Eksperimentel Cancerforskning

Free University of Brussels

Frontier Science and Technology Research Foundation Inc (FS)

Frontier Science & Technology Research Foundation, Inc.

Fujian Medical University

Galena Biopharma, Inc.

Gema Biotech S.A.

Gemeinschaftspraxis für Hämatologie und Onkologie

General Drug House Ltd., Bangkok

Generon (Shanghai) Corporation Ltd.

Genomic Health

Genor BioPharma Co., Ltd.

Georgetown University

Government of Belgium

Government of Brazil

Government of Canada

Government of China

Government of Denmark

Government of France

Government of India

Government of Japan

Government of Mexico

Grunenthal

Grupo Oncologico Cooperativo del Sur

Gruppo Italiano Mammella (GIM)

Guangdong Provincial Hospital of Traditional Chinese Medicine

Guangxi Medical University

Guizhou Medical University

Hacettepe University

Hainan People's Hospital

Hamamatsu Oncology Center

Harbin Medical University

Harvard University

HealthPartners Institute

Hebrew University

Hellenic Breast Surgeons Society

Hellenic Oncology Research Group

Henan Medical University

Hengrui Therapeutics, Inc.

Herbert Irving Comprehensive Cancer Center

Herlev Hospital

Herning Hospital

Hopital Arnaud de Villeneuve

Horizon Health Network

Hospital Carlos Haya

Hospital Clinico Lozano Blesa

Hospital Comarcal de Barbastro

Hospital de Jerez

Hospital de Pontevedra

Hospital de Torrevieja

Hospital General de Guadalajara

Hospital Madrid Norte Sanchinarro

Hospital Municipal de Badalona

Hospital Mutua de Terrassa

Hospital Provincial de Córdoba

Hospital Universitario Ntra. Sra. de La Candelaria

Hospital Universitario Puerta del Mar

Hospital Virgen de la Salud

Hospital Virgen de la Victoria

Hospital Virgen de los Lirios

Huazhong University of Science and Technology

H. Virgen de la Salud

IBEROAMERICAN COALITION FOR BREAST ONCOLOGY RESEARCH

Icelandic Breast Cancer Group

ICO Centre Regional Rene Gauducheau

Immunomedics

Imperial College London

INC Research

Indiana University

Indian Council of Medical Research

Inha University

Institut Bergonié

Institut de Cancérologie de la Loire (ICLN)

Institut de Cancérologie de Lorraine

Institut de Cancerologie de l'Ouest Paul Papin

Institut de Cancérologie Lucien Neuwirth

Institut Jules Bordet

Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes

Institut Paoli-Calmettes

Intarcia Therapeutics

Intas Pharmaceuticals Limited

International Breast Cancer Research Foundation

International Breast Cancer Study Group

International Cancer Research Group, United Arab Emirates

International Collaborative Cancer Group

IQVIA

Istanbul University

Istituto Clinico Humanitas - Rozzano (MI), Italy

Istituto Nazionale per lo Studio e la Cura dei Tumori

Istituto Oncologico della Svizzera Italiana IOSI

Istituto Oncologico Veneto IRCCS

Janssen Pharmaceutica NV

Japan Breast Cancer Research Group

Japan Clinical Oncology Group

Jiangsu Cancer Institute & Hospital

Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd

Jilin Provincial Tumor Hospital

Jilin University

Jinan University

Jina Pharmaceuticals, Inc.

Johns Hopkins University

Johnson and Johnson

John Wayne Cancer Institute

J. W. Goethe University

Karolinska Institute

Katholieke Universiteit Leuven

KhonKaen University

King Faisal Specialist Hospital

King Faisal University

Kumamoto University

Kunming Medical University

Kuopio University Hospital

Kyoto Breast Cancer Research Network

Kyoto Prefectural University of Medicine

Lambda Therapeutic Research Ltd

Latin American Cooperative Oncology Group

Leiden University

Lightpoint Medical Limited

Linyi Tumour Hospital

Loyola University

Ludwig Maximilians University

Luzerner Kantonsspital

Maastricht University

MacDonald Women's Hospital, Cleveland

MacroGenics

Maharat Hospital

MANTA 1 Study Italian Collaborative Group

Maria Sklodowska Curie Children's Hospital

Martin Luther University

Mastering Breast Cancer Initiative, LLC

Mayo Clinic

McGill University

McMaster University

Medical Oncology 2, Istituto Oncologico Veneto

Medical Research Council

Medical University of Vienna

Medidata Solutions

Medifocus, Inc.

Medivation

Merck Serono

Merrimack Pharmaceuticals

Miguel Hernández University

Mylan

Myrexis Inc.

Naestved Hospital

Nanchang University

National Cancer Center, Japan

National Cancer Center, Korea

National Cancer Institute, France

National Cancer Research Network

Nationale Centrum für Tumorerkrankungen

National Heart, Lung, and Blood Institute (NHLBI)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institute on Aging (NIA)

National Research Council of Thailand

National Shikoku Cancer Center

Neijiang Second People's Hospital

Nektar Therapeutics

Netherlands Cancer Institute

Newcastle University

New York Presbyterian Hospital

Nippon Kayaku Co.,Ltd.

North Central Cancer Treatment Group

North Eastern Germany Society of Gynaecologic Oncology

Northwestern University

Norwegian Breast Cancer Group

Novadaq Technologies Inc.

NRG Oncology

NSABP Foundation

OBI Pharma, Inc

Odonate Therapeutics, LLC

Oncocare Sonnenhof-Klinik Engeriedspital

OncoGenex Technologies

Oncotech

Onkologische Schwerpunktpraxis Eppendorf

Onyx

Orbis Medical Centre

Oregon Health and Science University

Ortho Biotech, Inc.

Osaka Medical Center for Cancer and Cardiovascular Diseases

Osakidetza

Ospedale Beata Vergine

Ospedale S. Giovanni Bellinzona

Otsuka

Parexel

Pennsylvania State University

People's Liberation Army of China

Pharma Nord

Pierre and Marie Curie University

Polyphor Ltd.

Postgraduate Institute of Medical Education and Research

PrECOG, LLC.

Prestige Brands

ProHEALTH Care Associates, LLP

Qilu Pharmaceutical Co., Ltd.

Qingdao University

Qinghai University

QUID Quality in Drugs and Devices Latin American Consulting SRL

Radiation Therapy Oncology Group

Radius Health

RdGG

Regina Elena Cancer Institute

Regional Oncologic Center

Regione Lombardia

Region Syddanmark

RemeGen

Royal Marsden Hospital NHS Trust

R-Pharm

Rush University

Rutgers University

Samsung

Samyang Biopharmaceuticals Corporation

Sandoz

Sanofi

Scandinavian Breast Group

SCRI Development Innovations

Seattle Genetics

Sentara

Shanghai Henlius Biotech

Shanghai Junshi Bioscience Co.,Ltd.

Shanghai Xuhui District Central Hospital

Shantou University

Shanxi Medical University

Sheffield Hallam University

Shenzhen University

Sichuan University

SOLTI Breast Cancer Research Group

Sopherion Therapeutics

South Tees Hospitals NHS Foundation Trust

Southwest Oncology Group

Spartanburg Regional Medical Center

Spectrum Pharmaceuticals

Spedali Civili di Brescia

State University of New York, Buffalo

Swedish Breast Cancer Group

Swedish Cancer Foundation

Swedish Cancer Society

Swiss Group for Clinical Cancer Research

Sygehus Sønderjylland

SynCore Biotechnology

Tanvex BioPharma

Tata Memorial Hospital

Technical University of Munich

Tel Aviv University

Temple University

Tesaro

Teva

The Australia and New Zealand Breast Cancer Trials Group (ANZBCTG)

The Belgian Society of Medical Oncology

The Christie NHS Foundation Trust

The Jones Institute

Theradex

The University of Hong Kong

Tibotec

Translational Research in Oncology

Trans Tasman Radiation Oncology Group

Tufts University

UNICANCER

Unidad Oncologica Del Neuquen

Universidad Autonoma de Barcelona

Universidad Autonoma de Madrid

Universidad Complutense de Madrid

Universidad de Murcia

Université catholique de Louvain

University of Amsterdam

University of Ankara

University of Arizona

University of Bari

University of Basel

University of Bern

University of Birmingham

University of Calgary

University of California, San Diego

University of Cambridge

University of Campania Luigi Vanvitelli

University of Catania

University of Cologne

University of Colorado, Denver

University of Crete

University of Duesseldorf

University of Duisburg-Essen

University of Durham

University of Edinburgh

University of Ferrara

University of Florence

University of Franche-Comté

University of Freiburg

University of Genoa

University of Glasgow

University of Guelph

University of Halle

University of Hamburg

University of Hawaii

University of Heidelberg

University of Helsinki

University of Las Palmas de Gran Canaria

University of Lausanne

University of Leeds

University of London

University of Lyon

University of Manchester

University of Michigan

University of Minho

University of Modena and Reggio Emilia

University of Montpellier

University of Naples Frederico II

University of Nice Sophia Antipolis

University of North Carolina at Chapel Hill

University of Nottingham

University of Oxford

University of Padova

University of Paris

University of Pennsylvania

University of Rochester

University of Seville

University of Sheffield

University of Southern Denmark

University of Sydney

University of Tennessee

University of Texas, Galveston

University of Texas, San Antonio

University of Toronto

University of Tuebingen

University of Ulm

University of Valencia

University of Vermont

University of Vienna

University of Western Ontario

University of Zaragoza

US Oncology

Utrecht University

Van Nuys Breast Center

Velindre NHS Trust

Vifor Inc.

Virginia Commonwealth University

Vita-Salute University of Milano. Italy

Warwick Medical School

Washington State University

Washington University in St. Louis

Weifang People's Hospital

Weihai Municipal Hospital

West German Study Group

Wuhan University

Wyeth

Xiamen University

Xinxiang Medical University

Yeshiva University

YM Biosciences

Yorkshire Regional Clinical Trials Research Unit

Zhejiang Hisun Pharmaceutical Co. Ltd.

ZonMw: The Netherlands Organisation for Health Research and Development

Organization Involved with Phase 2 Indications (582)

4Clinics

Abbott

Academic Emergency County Hospital Sibiu

Accelovance

Acorn Cardiovascular, Inc.

Activa Therapeutics

Actuate Therapeutics Inc.

Adastra Pharmaceuticals

ADIR Association

Advanced Accelerator Applications

Advanced Imaging Projects

Advanced Imaging Projects, LLC

Aegera Therapeutics

AEterna Zentaris

Affibody

Africa Middle East Cancer Intergroup

Agennix

Ahram Canadian University

Ain Shams University

AIO-Studien-gGmbH

Alexandria University

Alliance Pour La Recherche en Cancerologie

All India Institute of Medical Sciences

Alphamab Co., Ltd.

Alterity Therapeutics

Amarex Clinical Research

American College of Radiology

American Institute for Cancer Research (AICR)

American University of Beirut

Anne Arundel Health System Research Institute

Antisoma Research

Apices Soluciones S.L.

Aptium Oncology

Arbeitsgemeinschaft medikamentoese Tumortherapie

ARCAGY- GYNECO

Arithmos srl

Array BioPharma

Asociación Oncosur

Assistance Publique - Hôpitaux de Paris

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (ARTIC)

Associazione Italiana per la Ricerca sul Cancro

Astex Pharmaceuticals, Inc.

Atossa Genetics, Inc.

Aultman Health Foundation

AurKa Pharma Inc.

AVEO Pharmaceuticals

Avera Health

Avon Foundation

Ayala Pharmaceuticals, Inc,

Azienda Ospedaliera Istituti Ospitalieri Cremona

Azienda Ospedaliera San Gerardo di Monza

Azienda USL 4 Prato

Baylor University

BeiGene

Beijing Huanxing Cancer Hospital

Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Beni Suef University

BerGenBio ASA

Berufsverband Niedergelassener Gynäkologischer Onkologen in Deutschland e.V.

Besins Healthcare

Beta Pharma, Inc.

Bicycle Therapeutics

Big Ten Cancer Research Consortium

Biogen

BioLab 612 LLC

BioLite, Inc.

Biomedical Radiation Sciences

Bionovo

Biotech Pharmaceutical Co., Ltd.

Biotec Pharmacon ASA

BiPar Sciences

Birmingham Hematology/Oncology Associates

Boca Raton Regional Hospital

Boston University

Breast Cancer Now

BriaCell Therapeutics Corporation

BRIU GmbH

Brooklyn Immunotherapeutics

Bruckner Oncology

Burton Hospitals NHS Foundation Trust

Burzynski Research Institute

Cahaba Pharmaceuticals

Cairo University

California Breast Cancer Research Program

Calithera Biosciences

Canadian Institutes of Health Research (CIHR)

Cancer Centre and Institute of Oncology Warsaw

Cancer Insight, LLC

Cancer Research Group - Collaborative Group, Beirut, Lebanon.

Cancer Research Network

Cancer Treatment Centers of America

Cancer Treatment Research Foundation

CASI Pharmaceuticals, Inc.

Catharina Hospital, Eindhoven, The Netherlands

Cedars-Sinai Medical Center

Celcuity

Celldex Therapeutics

Celsion

Centre Georges Francois Leclerc

Centre Hospitalier de Saint-Brieuc

Centre Hospitalier du Luxembourg

Centre Jean Perrin

Centre Paul Strauss

CENTRE RENE HUGUENIN, SAINT CLOUD, FRANCE

Centro Nacional de Investigaciones Oncológicas

Centro Universitario contra el Cáncer

Chang Gung University

Chavah Pty Ltd

Chiltern International

China Ministry of Health

CHU Charleroi

CHU UCL Namur

CJ HealthCare Corp.

Cleveland BioLabs

Clínica Hospital Dr. Ismael Vázquez Ortiz ISSSTE, Queretaro Mexico

Clinical Center of Montenegro

Clinica Universidad de Navarra

Clinique Louis Cathy, Baudour, Belgium

Cliniques universitaires Saint-Luc

Clirest s.r.l.

Clovis Oncology

Columbia University

Commonwealth Foundation for Cancer Research

Complejo Hospitalario de Ávila

Concerto HealthAI

Conquer Cancer Foundation

Cortice Biosciences, Inc.

Criterium, Inc.

Croatian Cooperative Group for Clinical Research in Oncology

CTI BioPharma

CuraGen

Cyclacel Pharmaceuticals, Inc.

Cytheris

CytoDyn, Inc.

Cytogen

Cytokinetics

CytomX Therapeutics

CytoVac A/S

Damanhour University

Debiopharm

Department of Surgery, Koja General Hospital, Jakarta, Indonesia

Department of Veteran Affairs

Developmental Therapeutics Consortium

Dompe Pharmaceuticals

Dr. H. Bliss Murphy Cancer Center

Duke University

East Carolina University

Edward Hospital

Effector Therapeutics

Emek Medical Center

Emory University

Endocyte

Enzon

Epeius Biotechnologies

Esperas Pharma Inc.

Evelo Biosciences

Evgen Pharma

ExcellaBio LLC

Exelixis

Faculdade de Medicina do ABC

Faculty of Medicine Universitas Indonesia - Dr Cipto Mangunkusumo Hospital

Far Eastern Memorial Hospital

Fennec Pharma

FeRx

Fondation ARC

Fondazione Sandro Pitigliani

Fosun

Free University of Amsterdam

Fresenius

Fukushima Medical University

Fundació ACE

Fundacion Instituto Valenciano de Oncologia

Fundacion Oncosur

Fundación Pública Andaluza

Fundación Salud de los Andes

G1 Therapeutics, Inc.

Gachon University

Ganzhou City People's Hospital

Garden State Cancer Center

Gateway for Cancer Research

GEICAM, Spain

Gemeinschaftspraxis Onkologie Ravensburg

Gem Pharmaceuticals

General Electric

Generex Biotechnology Corp.

Genta

Genzyme

Georgia Center for Oncology Research & Education

Geron Corporation

Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH

Gilead Sciences

Glenmark Pharmaceuticals

Good Samaritan Foundation

Government of Belarus

Government of Colombia

Government of Russia

Government of Singapore

Government of Taiwan

Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)

Groupe Hospitalier Public Sud Oise

Grupo Oncológico Gallego

Gruppo Oncologico Italiano di Ricerca Clinica

GTx

Guangzhou University

Guy's and St Thomas Hospital

Halozyme Therapeutics

Hamilton Health Sciences Corporation

Hammoud Hospital University Medical Center

Hanmi Pharmaceutical

Hans and Mavis Lopater Foundation

Hefei University

Hellenic Cooperative Oncology Group

Hematology Oncology Consultants

HIS - Site Etterbeek - Ixelles - Belgium

Hoosier Cancer Research Network

Hopital Morges

Horizon Pharma

Hospital Auxilio Mutuo

Hospital do Cancer III - INCA

Hospital General Regional #1 IMSS, Queretaro México

Hospital General Universitario Gregorio Marañon

Hospital Interzonal General De Agudos Eva Peron

Hospital Medico TEC100, Queretaro México

Hospital Universitario de Fuenlabrada

Hospital Universitario Infanta Leonor

Hospital Universitario Madrid Sanchinarro

Humanitas University

Humboldt University

Huntington Memorial Hospital

Hutchison MediPharma

Icahn School of Medicine at Mount Sinai

IFOM

Immune System Key Ltd

Immunitor LLC

Immunovative Clinical Research

Immunovative Therapies

Immutep S.A.

Incyte

Infinity Pharmaceuticals, Inc.

Inflammatory Breast Cancer Network Foundation

Inje University

Innocrin Pharmaceutical

Inova Health System

Institut Català d'Oncologia

Institut National de la Santé Et de la Recherche Médicale, France

Instituto do Cancer do Estado de São Paulo

Instituto Nacional Canerologia

Instituto Nacional de Cancer, Brazil

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Instituto National de Cancerologia, Guatemala

Institut Régional du Cancer de Montpellier

Insurance CNP foundation

Insys Therapeutics Inc

International Drug Development Institute

Introgen Therapeutics

Ipsen

IRCCS CANDIOLO

Istituti Ospitalieri di Cremona

Istituto Superiore di Sanità

Iuliu Hatieganu University of Medicine and Pharmacy

Japan Breast Cancer Research Network

Jiangmen Central Hospital

Jinlin University

Johannes Gutenburg University

Kadmon

Kaiser Franz Josef Hospital

Kansai Medical University

Kaohsiung Medical University

Karyopharm Therapeutics Inc

Kazia Therapeutics Limited

Kepler University

K-Group Beta

KH Elisabethinen Linz

Kirax

Kliniken Essen-Mitte, Germany

Klus Pharma Inc.

Kom Op Tegen Kanker

Koordinierungszentren für Klinische Studien bzw. Zentren für klinische Studien

Kortuc Inc.

Kosin University

KuDOS

Kyoto University

Kyowa Hakko Kirin

Laboratorio Elea S.A.C.I.F. y A.

Lagos State University

Laval University

Leadiant Biosciences, Inc.

Leap Therapeutics, Inc.

Legacy Health System

Leo W. Jenkins Cancer Center

Ligand Pharmaceuticals

Lignan Research Inc.

LKH Feldkirch

Louise & Alan Edwards Foundation

Louisiana State University

Lowell General Hospital

Masaryk University

Mast Therapeutics

Maxygen, Inc.

MC Haaglanden

McKesson

MDS Pharma

Meabco A/S

Meddoc AS

Medical College of Wisconsin

Medical Oncology Centre of Rosebank

Medical Oncology & Hematology Associates of Northern Virginia

Medical University of Bialystok

Medical University of Graz

Medical University of South Carolina

Mediclinic Middle East

MediGene

MedImmune

MedSIR

Memorial Sloan-Kettering Cancer Center

Merck KGaA

Merus Labs

Methodist Cancer Center, Houston, Texas

Michigan Cancer Research Consortium

Midwestern Regional Medical Center

Millennium Pharmaceuticals

Mipharm SpA

Mirati Therapeutics Inc.

Modra Pharmaceuticals

Moorgreen Hospital, Southampton

Myelo Therapeutics GmbH

NanoString Technologies, Inc.

NantCell, Inc.

NantWorks

Nanyang Technological University

Napo Pharmaceuticals

National Autonomous University of Mexico

National Cancer Institute, Slovakia

National Center for Complementary and Integrative Health (NCCIH)

National Center for Research Resources (NCRR)

National Center of Oncology, Armenia

National Comprehensive Cancer Network

National Institute for Health Research, United Kingdom

National Institute of Oncology, Budapest

National Institutes of Health (NIH)

National OncoVenture

National University of Singapore

Neovii Biotech

NeuTec Pharma

New Hampshire Oncology-Hematology PA

NewLink Genetics Inc

New York University

NKMAX Co., Ltd.

Non-State Healtcare Institution Road Clinical Hospital of Open Joint Stock Company Russian Railways

Norwegian Cancer Society

Norwegian University of Life Sciences

Norwell, Inc.

NOW Foods

Odense University Hospital

OHSU Knight Cancer Institute

Olema Pharmaceuticals, Inc.

Oncology Practice, Glauchau

Oncology Specialties, Alabama

Oncology Specialties, PC

Oncology Therapeutic Development

Oncology Venture

Oncolytics Biotech

OncoPep, Inc.

OncoSec Medical Incorporated

Ono Pharmaceuticals

Ontario Institute for Cancer Research

Organisation for Oncology and Translational Research

Orion Corporation

Osaka Medical College

Osaka University

OSI Pharmaceuticals

Oslo Metropolitan University

Ospedale Sacro Cuore

Ozmosis Research Inc.

Palacky University

Panagen, Limited Liability Company

Pantarhei Bioscience

Papageorgiou General Hospital

Paracelsus Medical University

Pennies in Action

Perrigo

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Petrov Research Institute of Oncology

Petz, Aladar Korhaz, Onkoradiologiai Osztaly, Gyor, Hungary

Pharmaceutical Research Associates, Inc. (PRA)

Pharmacyclics

PharmaMar

Pharmatech

Philips

Philogen S.p.A.

photonamic GmbH & Co. KG

PIQUR Therapeutics AG

Pivotal S.L.

Plexxikon

Pomeranian Medical University

Poole Hospital NHS Foundation Trust

PositronPharma

Premiere Oncology

Premier Research Group

Prof. Dr. I. Chiricuta Institute of Oncology

Psicofarma S.A. de C.V.

Q2 solutions

Qingfeng Pharmaceutical Group

QPS

Quantum Immunologics, Inc.

QuantumLeap Healthcare Collaborative

Queen's University, Belfast

Recepta Biopharma

Regional Oncology Hospital, Bielsko-Biala, Poland

Repros Therapeutics

Rhode Island Hospital

Rhone-Poulenc Rorer

Robert W. Franz Cancer Center

Rogers Sciences Inc.

Russian Academy of Medical Sciences

Russian Cancer Research Center

Sahel General Hospital

Saint Luke's Health System

Sana Klinikum Lichtenberg, Berlin

San Antonio Military Medical Center

Scripps

Sermonix

Sermonix Pharmaceuticals Inc.

Servier

Shanghai CP Guojian Pharmaceutical Co.,Ltd.

Shanghai University of Traditional Chinese Medicine

Shenzhen Geno-Immune Medical Institute

Shenzhen Hank Bioengineering Institute

Siemens

Singapore General Hospital

Sinocelltech Ltd.

Smerud Medical Research Denmark

Solae, LLC

Sorlandet Hospital HF

South Eastern European Research Oncology Group

South-Eastern Norway Regional Health Authority

Southern Illinois University

South Sweden Breast Cancer Group

Spanish Clinical Research Network

Sponsor GmbH

SRI International

Stand Up To Cancer

Stanford University

State of Texas

St Augustinus Wilrijk

St. Jude Children's Hospital

St. Louis University

Stony Brook University

St.-Petersburg State Budgetary Healtcare Institution City Clinical Oncological Dispensary

St. Vincent Medical Center - Los Angeles

St. Vincent's Hospital-Manhattan

Susan G. Komen Breast Cancer Foundation

Sutter Health

Sykehuset Innlandet HF

Sykehuset i Vestfold HF

Sykehuset Ostfold

Synageva Biopharma

Syndax Pharmaceuticals

Synta Pharmaceuticals Corp.

Szent László Hospital

Taichung Veterans General Hospital

Taipei Medical University

Taipei Veteran General hospital

Tapimmune Inc.

Teikyo University

Telik

Temas srl

Tennessee Oncology, PLLC

Terry Fox Foundation

Texas Tech University

The Brain Tumour Charity

The Commonwealth Fund

The Dudley Group NHS Foundation Trust

The First People's Hospital of Changzhou

The First People's Hospital of Lianyungang

The Institute of Molecular and Translational Medicine, Czech Republic

The Methodist Hospital System

The National Cancer Center

The Royal Bournemouth Hospital

The University of Texas, Dallas

Thomayer's Hospital

Thong Chai Medical Institute Singapore

Tohoku University

Tracon Pharmaceuticals Inc.

Translational Breast Cancer Research Consortium

Translational Breast Cancer Research Consortium (TBCRC)

Translational Oncology Research International

Translational Research Informatics Center, Kobe, Hyogo, Japan

Triple Negative Breast Cancer Foundation

TTY Biopharm

Tyme, Inc

Uniformed Services University of the Health Sciences

Unimed Pharmaceuticals

Union Therapeutics

United States Army

Universidad Carlos III Madrid

Universidad de Cordoba

Universidad Nacional de Colombia

Università degli studi di Trieste

University Hospital of North Norway

University of Abacete

University of Adelaide

University of Alberta

University of Arkansas

University of Auckland

University of Bergen

University of Bordeaux

University of Brescia

University of Bristol

University of Caen-Normandie

University of California, Davis

University of California, Irvine

University of California, San Francisco

University of Chicago

University of Cincinnati

University of Connecticut

University of Erlangen-Nuremberg

University of Florida

University of Grenoble

University of Groningen

University of Illinois at Chicago

University of Indonesia

University of Iowa

University of Kansas

University of Kentucky

University of Lodz

University of Magdeburg

University of Malaga

University of Malaya

University of Maryland

University of Medicine and Dentistry of New Jersey

University of Melbourne

University of Milano Bicocca

University of Minnesota

University of Montreal

University of Nantes

University of Nebraska

University of New Mexico

University of North Dakota

University of Oslo

University of Parma

University of Patras

University of Roma La Sapienza

University of Sao Paulo

University of South Carolina

University of Southern California

University of Split

University of Stavanger

University of Tampere

University of Texas, Tyler

University of the Witwatersrand

University of Tokyo

University of Tromso

University of Turin

University of Turku

University of Utah

University of Virginia

University of Warwick

University of Wisconsin

Vanderbilt University

Veeda Clinical Research

VelosBio

Vestan, Inc.

Wake Forest University

Wayne State University

West Cancer Center

West China Hospital

Western Norway Regional Health Authority

West Virginia University

Wilex

Windsor Regional Cancer Center

Wiseman Research Initiatives, LLC

WiSP GmbH

Wuxi People's Hospital

Xinjiang Medical University

Yale University

Yiling Pharmaceutical Inc.

Zai Lab Pty. Ltd.

Zeneus Pharma

Zenith Epigenetics

Ziopharm

Zymeworks Inc.

Organization Involved with Phase 1 Indications (153)

Organization Involved with Other Experimental Indications (73)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.